跳至主要内容
临床试验/JPRN-UMIN000035602
JPRN-UMIN000035602已完成未知

Hydrogen gas inhalation randomized double blinded trial for Parkinson's disease - Hydrogen gas inhalation randomized double blinded trial for Parkinson's disease

Juntendo University Koshigaya Hospital0 个研究点目标入组 20 人开始时间: 2019年1月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Parkinsonism except Parkinson's disease modified Hoehn and Yahr stage 4~5 with dementia with lung disease with malignant tumor

研究者

相似试验

暂停
不适用
Hydrogen gas inhalation randomized double blinded trial for ulcerative colitislcerative colitis
JPRN-UMIN000042017Juntendo University Hospital20
进行中(未招募)
1 期
Ensayo randomizado, doble ciego, con doble enmascaramiento, de grupos paralelos para evaluar la eficacia y seguridad de RO4402257 como monoterapia en comparación con la monoterapia de metotrexato para pacientes con artritis reumatoide activa (AR)A randomized, double-blind, double-dummy, parallel group study to determine the efficacy and safety of RO4402257 monotherapy in comparison to methotrexate monotherapy in patients with active rheumatoid arthritis (RA).
EUCTR2005-003694-25-ESF. Hoffmann-La Roche Ltd200
尚未招募
4 期
AMBLE Trial: Iron Deficiency Anaemia in Major Cardiac, Abdominal and VascuLar surgery patients and Effect on functional outcomes
ACTRN12622001447741South Metropolitan Health Service240
进行中(未招募)
1 期
Human Rhinovirus (HRV16) challenge study of PrEP-001 in Asthmatic Subjects.Human Rhinovirus (HRV-16)MedDRA version: 18.0 Level: PT Classification code 10075163 Term: Human rhinovirus test System Organ Class: 10022891 - Investigations
EUCTR2015-004042-26-GBhVIVO Services Limited40
进行中(未招募)
不适用
Etude randomisée, en double aveugle, évaluant l'efficacité et la tolérance de l'analgésie par mélange équimolaire protoxyde d'azote-oxygène contre oxygène chez des patients bénéficiant d'injection endovésicale de toxine botulique de type A - PROTOTOXPatient présentant une hyperactivité vésicale neurologique et bénéficiant d'injection endovésicale de toxine botulique de type AMedDRA version: 8.1Level: PTClassification code 10002182Term: Hyperactivité vésicale neurologique
EUCTR2006-005352-32-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)